Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fallopian tube carcinoma.

M D Brown, E I Kohorn, D S Kapp

    International Journal of Radiation Oncology, Biology, Physics
    |March 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancers.

    Gynecologic oncology·2019
    Same author

    Do imaging techniques, grey scale ultrasound, color doppler flow ultrasound and magnetic resonance imaging provide clinically useful information during the therapy of nonmetastatic gestational trophoblastic neoplasia.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2018
    Same author

    A Comparative Study of Minimally Invasive Versus Open Hysterectomy for Women With Fibroid Uterus - A Nationwide Study of 65,216 Patients.

    Journal of minimally invasive gynecology·2016
    Same author

    Prognostic discrimination of subgrouping node-positive endometrioid uterine cancer: location vs nodal extent.

    British journal of cancer·2011
    Same author

    Endometrial stromal sarcoma: a population-based analysis.

    British journal of cancer·2008
    Same author

    The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients.

    British journal of cancer·2007
    Same journal

    Highly Variable, Complex, and Contextual: The Business of Radiation Oncology Practice.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Corrigendum to 'Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation' [International Journal of Radiation Oncology*Biology*Physics Volume 112, Issue 5, 1 April 2022, Pages 1243-1255].

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Multicenter external validation of normal tissue complication probability models for radiation-induced primary hypothyroidism in head and neck cancer survivors with long-term endocrine outcomes.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    THGEM-Based Air Ionization Chamber for Online Dose Monitoring in Conventional and FLASH Radiotherapy.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Single Percussive Ventilation Breath-hold Imaging and Delivery in Lung Tumor Stereotactic Ablative Radiation Therapy: Initial Observations From a Prospective Clinical Trial.

    International journal of radiation oncology, biology, physics·2026
    Same journal

    Proton beam therapy in nonmetastatic rhabdomyosarcoma: Outcome, prognostic factors and the effect of timing of radiation therapy.

    International journal of radiation oncology, biology, physics·2026
    See all related articles

    Adjuvant therapy is crucial for fallopian tube carcinoma, as complete resection alone does not ensure remission. Early-stage patients may benefit from radiation or chemotherapy to improve outcomes in this rare gynecologic cancer.

    Area of Science:

    • Gynecologic Oncology
    • Surgical Oncology
    • Radiation Oncology

    Background:

    • Fallopian tube carcinoma is a rare gynecologic malignancy.
    • Complete surgical resection is the primary treatment, but recurrence rates remain high.
    • The need for effective adjuvant therapies is critical.

    Purpose of the Study:

    • To review outcomes of fallopian tube carcinoma patients treated at Yale-New Haven Medical Center.
    • To evaluate the efficacy of adjuvant therapies and surgical interventions.
    • To identify prognostic factors and recommend optimal treatment strategies.

    Main Methods:

    • Retrospective review of 21 patients with fallopian tube carcinoma.
    • Analysis of treatment modalities including surgery, radiation, and chemotherapy.

    Related Experiment Videos

  • Evaluation of recurrence rates, survival, and impact of second-look surgery.

    • Main Results:

    • High recurrence rates were observed in Stage I and completely resected Stage II/III disease (8/14 patients).
    • Most disease-related deaths occurred within two years post-diagnosis, irrespective of initial resection.
    • Late recurrences were noted up to nine years after diagnosis; negative second-look surgery did not guarantee remission.

    Conclusions:

    • Adjuvant therapy is strongly indicated for fallopian tube carcinoma, even after complete resection.
    • Whole abdomino-pelvic radiation is recommended for resected disease without significant residual bulk.
    • Chemotherapy presents an alternative adjuvant option for early-stage disease and palliative care for advanced/recurrent cases.